SCHEMBL17599396

SCHEMBL17599396

COC(=O)c1ccc(Cl)c(-c2ccc(NS(=O)(=O)c3c(C)c(C)cc(C)c3C)c3ccc(C)nc23)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 4/20 0.38
▸ CMA1 P23946 5/20 0.38
▸ CYP2C9 P11712 4/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ KDM4E B2RXH2 3/20 0.37
▸ TSHR P16473 3/20 0.37
▸ TP53 P04637 1/20 0.37
▸ ALDH1A1 P00352 4/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CRHBP P24387 1/20 0.37
▸ CRHR2 Q13324 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ PKM P14618 1/20 0.37
▸ ACLY P53396 1/20 0.36
▸ NFE2L2 Q16236 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599349 0.80 MEN1 (0.43) KEAP1SMN1; SMN2KDM4ETSHRTP53
SCHEMBL17599499 0.64 KEAP1 (0.48) KEAP1KDM4ETSHRTP53ALDH1A1
SCHEMBL16502691 0.63 TP53 (0.46) SMN1; SMN2KDM4ETSHRTP53ALDH1A1
SCHEMBL17599346 0.63 CDC25B (0.45) KEAP1SMN1; SMN2KDM4ETSHRALDH1A1
SCHEMBL17599324 0.63 MEN1 (0.47) KEAP1KDM4ETSHRTP53ALDH1A1
SCHEMBL20504366 0.62 TP53 (0.55) SMN1; SMN2KDM4ETSHRTP53ALDH1A1
SCHEMBL17599380 0.62 MEN1 (0.44) KEAP1CMA1CYP2C9SMN1; SMN2KDM4E
SCHEMBL17110579 0.62 NTRK1 (0.48) SMN1; SMN2KDM4ETSHRTP53ALDH1A1
SCHEMBL14389382 0.62 KDM4E (0.70) CYP2C9SMN1; SMN2KDM4ETSHRALDH1A1
SCHEMBL16509474 0.62 TP53 (0.42) SMN1; SMN2KDM4ETSHRTP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback